Replies to post #774267 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Ooh-wee, that’s laying on thick!!! Wow. No matter how you try to spin it all the Cognate cash went to the CEO-CFO’s private company not to NWBO retail shareholders. She even personally received back NWBO shares. Clearly Cognate wasn’t bought for $800M because of their DC capability. And now Cognate is in the hands of a large global company with DC’s being just one of many cell services. Advent will likely go down the same way. Just look at their website and try to find a mention of the company’s CMO/CDMO. Goodluck.🤷‍♀️

>>Human Immune Cells Overview

B Cells

Dendritic Cells

Granulocytes

Macrophages

Monocytes

Natural Killer Cells

PBMCs

T Cells Portfolio

[manibiotech]

I think this has been discussed several times before you started posting . Let us know where all the revenue of Advent comes from . Their yearly revenue report was posted by someone here few months ago . Don't see the point of rehashing those points . But there are some , or more than some here , who don't agree with your portrayal of cognate and advent , knowing who had/has ownership and now majority stake etc etc and where most of revenue comes from . This could have been done as fully owned subsidiary of NWBO and shareholders actually built equity from the money which has been just expense over the years , in my opinion .